November 18 - 20, 2019 | DoubleTree Suites by Hilton Boston - Cambridge
Pharma Contract Manufacturing: Risk Management, Quality, Tech Transfer & Business Continuity
Now more than ever, pharmaceutical and biotech companies are using Contract Manufacturing Organizations (CMOs) to help them with scalability and focusing on drug discovery and drug marketing. CMOs are a response to the competitive international nature of the pharmaceutical market as well as the increasing demand for outsourced services.
IQPC’s Pharma Contact Manufacturing event (geared for big pharma and small to mid size biotechs) will focus on technical rather than relationship building topics.
Featured Speakers
Senior Director, Biotherapeutics and Vaccines Outsourcing,
Pfizer
Head of Operations
CuriRx
Sr. Supply Chain Specialist
Heron Therapeutics, Inc.
Vice President, Biologics
Catalent Pharma Solutions
SVP Technical Operations
Iovance Biopharmaceuticals
Director of CMC
Centrexion Therapeutics
Quality Engineering Lead
Terumo Medical
Senior Director of Analytical Development, Contract Manufacturing Team
Promedior Inc.
Healthcare Futurist, SVP, Quality
Lumicell
Compliance QA, Quality
Ocular Therapeutix
Associate Director, Quality at Ocular Therapeutix
Ocular Therapeutix
What to expect in 2019
Interactive
Discussion Groups broken down by big pharma focus and small pharma focus
An
interactive workshop on preparing now for 2023 interoperability
An
exhibition hall featuring CMOs and solution providers
Thought
provoking session on risk management and tech transfer strategies for expanding
patient access
A
unique approach to vendor selection that focuses on what you can live with
versus what’s a deal breaker
Practical
case studies showcasing technical and technological innovation in CMO
capabilities
